ABO(H) antigens and beta-2 microglobulin in transitional cell carcinoma. Predictors of response to intravesical bacillus calmette-guerin
Open Access
- 15 June 1991
- Vol. 67 (12) , 3024-3028
- https://doi.org/10.1002/1097-0142(19910615)67:12<3024::aid-cncr2820671216>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Retrospective study of efficacy of intravesical bcg alone in treatment of superficial bladder cancerUrology, 1986
- Bacillus Calmette-Guerin for Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1986
- Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment ResultsJournal of Urology, 1985
- Bladder Cancer ImmunotherapyJournal of Urology, 1982
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- ABH Isoantigens in Stage O Papillary Transitional Cell Carcinoma of the Bladder: Correlation with Biological BehaviorJournal of Urology, 1982
- Correlation of the Cell Surface Antigens with Stage and Grade in Cancer of the BladderJournal of Urology, 1979
- Tissue Blood-Group Antigens and Prognosis in Low Stage Transitional Cell Carcinoma of the BladderJournal of Urology, 1978
- The Cell Surface Antigen A, B or O(h) as an Indicator of Malignant Potential in Stage a Bladder Carcinoma: Preliminary ReportJournal of Urology, 1978
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976